CGCN GROUP, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $75,000.00 income · posted Jul 19, 2025

Bills named in this filing 2

Lobbying activity 2

Health Issues

Access to innovative non-opioid medicines.

Medicare/Medicaid

Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.